Syngene brings out novel approach to treat acute myeloid leukaemia
Syngene brings out novel approach to treat acute myeloid leukaemia
24 February 2021 | News The article details important findings and solutions that were brought forth by the scientists in the novel approach for the treatment of Acute Myeloid Leukaemia (AML)
Source credit: Shutterstock
Two Syngene scientists, Vijaykumar Chennupati and Balaji Ramachandran, co-authored an article titled ‘Selective recruitment of γδ T cells by a bispecific antibody for the treatment of acute myeloid leukaemia’ that got published in Leukemia, a prestigious international journal from the Nature Publishing Group. The scientists designed and conducted the experiments and performed the data analysis and helped with interpretation.